Glutathione trapping to measure microsomal oxidation of furan to cis-2-butene-1,4-dial

Drug Metabolism and Disposition

Volumn 33, Issue 10, 2005, Pages 1453-1458

  Peterson, Lisa A ^a   Cummings, Meredith E ^a   Vu, Choua C ^a   Matter, Brock A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 BUTENE 1,4 DIAL; ALDEHYDE DERIVATIVE; CYTOCHROME P450 2E1; FURAN; GLUTATHIONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARCINOGEN DNA INTERACTION; CONTROLLED STUDY; ELECTROCHEMISTRY; ENZYME METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER CLEARANCE; LIVER MICROSOME; LIVER MICROSOME METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES COMPARISON; SUBSTITUTION REACTION;

ALDEHYDES; ANIMALS; BIOLOGICAL ASSAY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 CYP2E1; ELECTROCHEMISTRY; FURANS; GLUTATHIONE; HUMANS; MALE; MICROSOMES, LIVER; OXIDATION-REDUCTION; RATS; RATS, INBRED F344;

ANIMALIA;

EID: 24944560423     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.105.004432     Document Type: Article

References (28)

1. Alvarez-Diez TM and Zheng J (2004) Detection of glutathione conjugates derived from 4-ipomeanol metabolism in bile of rats by liquid chromatography-tandem mass spectrometry. Drug Metab Dispos 32:1345-1350.
2. Baer BR, Rettie AE, and Henne KR (2005) Bioactivation of 4-ipomeanol by CYP4B1: adduct characterization and evidence for an enedial intermediate. Chem Res Toxicol 18:855-864.
3. 14C]furan in the male F344 rat. J Toxicol Environ Health 34:245-257.
4. Burns JA, Butler JC, Moran J, and Whitesides GM (1991) Selective reduction of disulfides by tris(2-carboxyethyl)phosphine. J Org Chem 56:2648-2650.
5. 2-etheno- 2′-deoxyguanosine adducts by cis-2-butene-1,4-dial, a reactive metabolite of furan. Chem Res Toxicol 17:1607-1613.
6. 4 and its distribution in air. Clin Toxicol 6:109-124.
7. Carfagna MA, Held SD, and Kedderis GL (1993) Furan-induced cytolethality in isolated rat hepatocytes: correspondence with in vivo dosimetry. Toxicol Appl Pharmacol 123:265-273.
8. Chen LJ, Hecht SS, and Peterson LA (1995) Identification of cis-2-butene-1,4-dial as a microsomal metabolite of furan. Chem Res Toxicol 8:903-906.
9. Chen LJ, Hecht SS, and Peterson LA (1997) Characterization of amino acid and glutathione adducts of cis-2-butene-1,4-dial, a reactive metabolite of furan. Chem Res Toxicol 10:866-874.
10. Elmore LW and Sirica AE (1993) "Intestinal-type" of adenocarcinoma preferentially induced in right/caudate liver lobes of rats treated with furan. Cancer Res 53:254-259.
11. Gan J, Harper TW, Hsueh MM, Qu Q, and Humphreys WG (2005) Dansyl glutathione as a trapping agent for the quantitative estimation and identification of reactive metabolites. Chem Res Toxicol 18:896-903.
12. Guengerich FP (1982) Microsomal enzymes involved in toxicology-analysis and separation, in Principles and Methods of Toxicology (Hayes AW ed) pp 609-634, Raven Press, New York.
13. International Agency for Research on Cancer (1995) Furan. Dry Cleaning, Some Chlorinated Solvents and Other Industrial Chemicals, vol. 53, p 393, IARC, Lyon.
14. Kedderis GL, Carfagna MA, Held SD, Batra R, Murphy JE, and Gargas ML (1993) Kinetic analysis of furan biotransformation by F-344 rats in vivo and in vitro. Toxicol Appl Pharmacol 123:274-282.
15. Kedderis GL and Held SD (1996) Prediction of furan pharmacokinetics from hepatocyte studies: comparison of bioactivation and hepatic dosimetry in rats, mice and humans. Toxicol Appl Pharmacol 140:124-130.
16. Krijt J, Vackova M, and Kozich V (2001) Measurement of homocysteine and other aminothiols in plasma: advantages of using tris(2-carboxyethyl)phosphine as reductant compared with tri-n-butylphosphine. Clin Chem 47:1821-1828.
17. Maga J (1979) Furans in foods. Crit Rev Food Sci Nutr 11:355-366.
18. Manna L, Valvo L, and Betto P (1999) Determination of oxidized and reduced glutathione in pharmaceuticals by reversed-phase high performance liquid chromatography with dual electrochemical detection. J Chromatogr A 846:59-64.
19. Maronpot RR, Giles HD, Dykes DJ, and Irwin RD (1991) Furan-induced hepatic cholangiocarcinomas in Fischer 344 rats. Toxicol Pathol 19:561-570.
20. Melnyk S, Pogribna M, Pogribny I, Hine RJ, and James SJ (1999) A new HPLC method for the simultaneous determination of oxidized and reduced plasma aminothiols using coulometric electrochemical detection. J Nutr Biochem 10:490-497.
21. Mugford CA, Carfagna MA, and Kedderis GL (1997) Furan-mediated uncoupling of hepatic oxidative phosphorylation in Fischer-344 rats: an early event in cell death. Toxicol Appl Pharmacol 144:1-11.
22. 1 mice. NTP Technical Report No. 402. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health Research Triangle Park, NC.
23. National Toxicology Program (2000) Ninth Report on Carcinogens. U.S. Department of Health and Human Services, Washington, DC.
24. Parmar D and Burka LT (1993) Studies on the interaction of furan with hepatic cytochrome P-450. J Biochem Toxicol 8:1-9.
25. Peterson LA, Naruko KC, and Predecki D (2000) A reactive metabolite of furan, cis-2-butene-1,4-dial, is mutagenic in the Ames assay. Chem Res Toxicol 13:531-534.
26. Remião F, Carmo H, Carvalho F, and Bastos ML (2000) Simultaneous determination of reduced and oxidized glutathione in freshly isolated rat hepatocytes and cardiomyocytes by HPLC with electrochemical detection. Biomed Chromatogr 14:468-473.
27. Smith KS, Smith PL, Heady TN, Trugman JM, Harman WD, and Macdonald TL (2003) In vitro metabolism of tolcapone to reactive intermediates: relevance to tolcapone liver toxicity. Chem Res Toxicol 16:123-128.
28. Tang W, Stearns RA, Wang RW, Chiu SH, and Baillie TA (1999) Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac. Chem Res Toxicol 12:192-199.